MTOR and glioblastoma: Another mTOR inhibitor, everolimus, is being investigated in multiple Phase I and Phase II studies in GBM in combination with repurposed small-molecule inhibitors such as sorafenib, ribociclib and dasatinib [112,113,114,115,116].